Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
RadNet reaffirms FY22 revenue view $1.360B-$1-410B, consensus $1.39B » 06:11
08/09/22
08/09
06:11
08/09/22
06:11
RDNT

RadNet

$21.16 /

+0.46 (+2.22%)

Raises FY22 CapEx view to…

Raises FY22 CapEx view to $90M-$95M from $88M-$93M. Reaffirms FY22 Adjusted EBITDA view $208M-$218M; Cash Interest Expense view $27M-$32M; and Free Cash Flow view $80M-$90M.

ShowHide Related Items >><<
RDNT RadNet
$21.16 /

+0.46 (+2.22%)

RDNT RadNet
$21.16 /

+0.46 (+2.22%)

08/12/21
Fly Intel: Top five analyst initiations
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Barclays
RadNet initiated with an Overweight at Barclays
RDNT RadNet
$21.16 /

+0.46 (+2.22%)

Earnings
RadNet reports Q2 adjusted EPS 15c, consensus 5c » 06:08
08/09/22
08/09
06:08
08/09/22
06:08
RDNT

RadNet

$21.16 /

+0.46 (+2.22%)

Reports Q2 revenue…

Reports Q2 revenue $354.4M, consensus $348.94M. Howard Berger, President and CEO of RadNet, commented, "Our financial metrics continue to track towards the full-year guidance levels, which we revised upwards in conjunction with issuing our first quarter results. While we drove aggregate and same center revenue growth during the second quarter, we continue to experience the impacts of inflation, especially with respect to the cost of our labor force, certain Medicare reimbursement cuts and COVID-19. When we created our guidance levels, we anticipated absorbing $15M of additional costs of salaries and benefits as well as $7.4M of Medicare reimbursement reductions. We remain confident that incremental revenue and growth in the second half of 2022 from new centers, additional joint ventures, tuck-in acquisitions and various operating initiatives should mitigate some of these challenges."

ShowHide Related Items >><<
RDNT RadNet
$21.16 /

+0.46 (+2.22%)

RDNT RadNet
$21.16 /

+0.46 (+2.22%)

08/12/21
Fly Intel: Top five analyst initiations
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Barclays
RadNet initiated with an Overweight at Barclays
RDNT RadNet
$21.16 /

+0.46 (+2.22%)

Over a quarter ago
Hot Stocks
RadNet obtains FDA clearances for DeepHeatlh Saige-DX, Quantib Prostate 2.0 » 06:13
05/16/22
05/16
06:13
05/16/22
06:13
RDNT

RadNet

$17.87 /

+0.915 (+5.40%)

RadNet announced that it…

RadNet announced that it has received FDA clearances for its DeepHeatlh Saige-DX mammography and Quantib Prostate 2.0 MRI artificial intelligence algorithms.

ShowHide Related Items >><<
RDNT RadNet
$17.87 /

+0.915 (+5.40%)

08/12/21
Fly Intel: Top five analyst initiations
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Barclays
RadNet initiated with an Overweight at Barclays
RDNT RadNet
$17.87 /

+0.915 (+5.40%)

Earnings
RadNet raises FY22 revenue view to $1.36B-$1.41B from $1.35B-$1.4B » 06:09
05/09/22
05/09
06:09
05/09/22
06:09
RDNT

RadNet

$19.00 /

-0.965 (-4.83%)

FY22 consensus $1.38B.…

FY22 consensus $1.38B. Raises FY22 adjusted EBITDA view to $208M-$218M from $205M-$215M. Raises FY22 CapEx view to $88M-$93M from $85M-$90M. Dr. Howard Berger, President and CEO of RadNet, commented, "Despite being impacted in January by the Omicron variant of COVID-19, we produced the highest first quarter Revenue and Adjusted EBITDA from our imaging center operations in our company's history. Revenue increased 8.2% and Adjusted EBITDA increased 4.1% from last year's first quarter, after excluding the AI reporting segment and adjusting for CARES Act Provider Relief Funds received in last year's first quarter. Given the positive trends we are experiencing in our business and the strong financial performance of the first quarter, we have elected to revise certain guidance levels upwards in anticipation of financial results that we project to exceed our original expectations. We have increased 2022 guidance ranges for Revenue and Adjusted EBITDA."

ShowHide Related Items >><<
RDNT RadNet
$19.00 /

-0.965 (-4.83%)

08/12/21
Fly Intel: Top five analyst initiations
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Barclays
RadNet initiated with an Overweight at Barclays
RDNT RadNet
$19.00 /

-0.965 (-4.83%)

Earnings
RadNet reports Q1 adjusted EPS (15c), consensus 0c » 06:07
05/09/22
05/09
06:07
05/09/22
06:07
RDNT

RadNet

$19.00 /

-0.965 (-4.83%)

Reports Q1 revenue…

Reports Q1 revenue $341.8M, consensus $330.41M.

ShowHide Related Items >><<
RDNT RadNet
$19.00 /

-0.965 (-4.83%)

08/12/21
Fly Intel: Top five analyst initiations
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Barclays
RadNet initiated with an Overweight at Barclays
RDNT RadNet
$19.00 /

-0.965 (-4.83%)

Earnings
RadNet raises FY22 revenue view to $1.3B-$1.35B from $1.25B-$1.3B » 06:05
03/01/22
03/01
06:05
03/01/22
06:05
RDNT

RadNet

$24.71 /

+0.32 (+1.31%)

FY22 consensus $1.4B.…

FY22 consensus $1.4B. Raises FY22 adjusted EBITDA view to $210M-$220M from $180M-$190M.

ShowHide Related Items >><<
RDNT RadNet
$24.71 /

+0.32 (+1.31%)

08/12/21
Fly Intel: Top five analyst initiations
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Barclays
RadNet initiated with an Overweight at Barclays
RDNT RadNet
$24.71 /

+0.32 (+1.31%)

Earnings
RadNet reports Q4 adjusted EPS 13c, consensus 19c » 06:03
03/01/22
03/01
06:03
03/01/22
06:03
RDNT

RadNet

$24.71 /

+0.32 (+1.31%)

Reports Q4 revenue…

Reports Q4 revenue $333.2M, consensus $348.34M

ShowHide Related Items >><<
RDNT RadNet
$24.71 /

+0.32 (+1.31%)

08/12/21
Fly Intel: Top five analyst initiations
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Barclays
RadNet initiated with an Overweight at Barclays
RDNT RadNet
$24.71 /

+0.32 (+1.31%)

Conference/Events
RadNet to hold a conference call » 10:55
01/27/22
01/27
10:55
01/27/22
10:55
RDNT

RadNet

$24.38 /

+0.1 (+0.41%)

RadNet CEO Berger,…

RadNet CEO Berger, President Sorensen of DeepHealth, CEO Harte of Aidence and CEO Uiterweer of Quantib hold a conference call to discuss RadNet's Artificial Intelligence strategy on January 27 at 11 am. Webcast Link

ShowHide Related Items >><<
RDNT RadNet
$24.38 /

+0.1 (+0.41%)

08/12/21
Fly Intel: Top five analyst initiations
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Barclays
RadNet initiated with an Overweight at Barclays
RDNT RadNet
$24.38 /

+0.1 (+0.41%)

RDNT RadNet
$24.38 /

+0.1 (+0.41%)

Conference/Events
RadNet to hold a conference call » 09:55
01/27/22
01/27
09:55
01/27/22
09:55
RDNT

RadNet

$24.39 /

+0.11 (+0.45%)

RadNet CEO Berger,…

RadNet CEO Berger, President Sorensen of DeepHealth, CEO Harte of Aidence and CEO Uiterweer of Quantib hold a conference call to discuss RadNet's Artificial Intelligence strategy on January 27 at 11 am. Webcast Link

ShowHide Related Items >><<
RDNT RadNet
$24.39 /

+0.11 (+0.45%)

08/12/21
Fly Intel: Top five analyst initiations
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Barclays
RadNet initiated with an Overweight at Barclays
RDNT RadNet
$24.39 /

+0.11 (+0.45%)

RDNT RadNet
$24.39 /

+0.11 (+0.45%)

Earnings
RadNet backs FY21 revenue view$1.3B-$1.35B, consensus $1.34B » 06:09
11/08/21
11/08
06:09
11/08/21
06:09
RDNT

RadNet

$34.56 /

+2.17 (+6.70%)

Raises FY21 adjusted…

Raises FY21 adjusted EBITDA view to $210M-$220M from $200M-$210M. Raises FY21 free cash flow view to $80M-$90M from $75M-$85M.

ShowHide Related Items >><<
RDNT RadNet
$34.56 /

+2.17 (+6.70%)

RDNT RadNet
$34.56 /

+2.17 (+6.70%)

08/12/21
Fly Intel: Top five analyst initiations
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Raymond James
RadNet downgraded to Market Perform from Outperform at Raymond James
08/12/21 Barclays
RadNet initiated with an Overweight at Barclays
RDNT RadNet
$34.56 /

+2.17 (+6.70%)

RDNT RadNet
$34.56 /

+2.17 (+6.70%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.